Medical insurance 'online' pharmaceutical companies to take advantage of the layout
Since 2014, the Internet medical development is very rapid, but there is always a bottleneck, that is, how the health insurance payment. Recently, the National Health Insurance Bureau issued a document specifically on this issue, making specific provisions on the price of Internet medical services and health insurance payments, allowing the industry to see a brighter future for development. It is not only a benefit to the Internet medical industry, but also has a profound impact on the pharmaceutical industry, which is expected to change the traditional pattern of pharmaceutical distribution and give rise to new Internet sales.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-07-08
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Analysis Of The Advantages Of Generic Medicine In The Chinese Market
-
Industry: Suggestions To Focus On Transformation Opportunities For Three Types Of Chinese Medicine Companies
-
Global drug development: Asia on the rise
-
Chinese medicine traceability to 20 pharmaceutical enterprises began to pilot
-
Sun Pharma Halts US Expansion Amid 25 Percent Tariff Threat Net Profit Drops 20 Percent
-
JB Pharma Q1 Net Profit Surges 14 Percent to ₹202 Crore Revenue Hits ₹1094 Crore with 30 Percent EBITDA Margin
-
Mounjaro Reduces Heart Events by 8 Percent More Than Trulicity in 13,000-Patient Diabetes Trial
-
Bayer Sets Aside $1.37 Billion for Roundup Lawsuits Raises 2025 Sales Forecast to €48 Billion
-
Trump Pressures 17 Pharma CEOs to Match US Drug Prices with Global Lows September 29 Deadline Set
-
Moderna to Cut 10 Percent of Staff as COVID Vaccine Sales Plunge Stock Drops 4 Percent
Recommend Reading
-
Alipay, Baidu, and iFlytek Win Big—As the Government Spends $1.1 Billion on AI Healthcare, Is This a Lifeline or a Feeding Frenzy for Tech Giants?
-
Mounjaro Usage Doubles in June Sales Surge by 18 in India
-
Pfizer Warns Germany: Drug Pricing Could Put Investment at Risk
-
J&J VAT Dispute Threatens Free Medicine Access in Britain
-
Betting on Next-Generation Metabolic Therapies: Pfizer’s Big Wager on Metsera and Its Strategic Reshaping in China
-
China Energy Group Appoints Xu Xinfu as Board Director and Deputy Party Secretary Ranks 84th in Fortune Global 500
-
Chinese Ammonium Sulfate Market Stops Rising and Falls (5.14-5.21)
-
Mitsubishi Chemical to End Toner Resin Production by March 2026 Plans 400 Billion Yen Asset Exit
-
Low Levels Across the Entire Cycle Combined with Converging Moving Averages—The Turning Point for Melamine’s Price Decline Is Nearing
-
BASF and CATL Sign Strategic Pact for Advanced Cathode Materials 60000 Tons High-Nickel Output by 2025